San Diego – April 24, 2015 – Cooley advised Cidara Therapeutics, Inc. on its initial public offering. Cidara, headquartered in San Diego, California, is a biotechnology company focused on the discovery, development and commercialization of novel anti-infectives for the treatment of diseases that are inadequately addressed by current standard-of-care therapies. The company trades on The NASDAQ Global Market under the symbol "CDTX."

About Cooley LLP

Cooley's lawyers solve legal issues for entrepreneurs, investors, financial institutions and established companies. Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, often where innovation meets the law.

Cooley has 850 lawyers across 12 offices in the United States, China and Europe.